Correction: Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma by Ye Song et al.
Song et al. Molecular Cancer 2014, 13:235
http://www.molecular-cancer.com/content/13/1/235CORRECTION Open AccessCorrection: Alpha-enolase as a potential cancer
prognostic marker promotes cell growth,
migration, and invasion in glioma
Ye Song1,2†, Qisheng Luo1,3†, Hao Long1†, Zheng Hu1, Tianshi Que1, Xi’an Zhang1, Zhiyong Li1, Gang Wang1,
Liu Yi1, Zhen Liu2,4*, WeiYi Fang2* and Songtao Qi1*Correction
After the publication of this work [1] it was brought to
the authors’ attention that the U251-pLVTHM panel in
Figure fiveB and the U251 negative control (NC) panel in
Figure fiveD contained a duplication in error. The correct
version of Figure five (Figure 1 here) is given below.
The authors regret any inconvenience that this inaccur-
acy may have caused.
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Figure 1 Stably inhibited ENO1 expression decreases cell migration and invasion. (A). Stablydownregulating ENO reduced the migration
ability of shENO1-U251 and shENO1-U87 cells in vitro. (B). Stably suppressed ENO1 reduced in vitro invasion of shENO1-U251 and shENO1-U87
cells. (C). Transiently downregulated ENO1 dramatically decreased the migration ability of U251 and U87 cells in vitro. (D). Transiently suppressed
ENO1 inhibited in vitro invasion of U251 and U87 cells. Data were presented were presented as mean ± SD for three independent experiments.
*P < 0.05, statistically significant difference.
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